Cautious US majors curb annual spend
Recovering oil prices will not be enough to convince producers to stump up additional cash, but investors may still benefit from a substantial dividend pay-out
Market volatility is set to continue to constrain annual capex spend among US majors and ‘superindies’, even as the rollout of Covid-19 vaccines boosts oil prices and the prospect of a return to normal economic activity. Operators in the US shale patch were particularly burned by the economic downturn last year, and the largest US firms remain wary about overextending themselves. In 2020, the trio of ExxonMobil, Chevron and ConocoPhillips posted a colossal combined $30.2bn loss as oil prices plunged and energy demand vanished. ExxonMobil recorded the biggest loss and is again cutting capex. The major suffered a $22bn loss in 2020 and was forced to slice $10bn from its 2019 capex budget, a 32
Also in this section
8 December 2025
The Caribbean country’s role in the global oil market is significantly diminished, but disruptions caused by outright conflict would still have implications for US Gulf Coast refineries
5 December 2025
Mistaken assumptions around an oil bull run that never happened are a warning over the talk of a supply glut
4 December 2025
Time is running out for Lukoil and Rosneft to divest international assets that will be mostly rendered useless to them when the US sanctions deadline arrives in mid-December
3 December 2025
Aramco’s pursuit of $30b in US gas partnerships marks a strategic pivot. The US gains capital and certainty; Saudi Arabia gains access, flexibility and a new export future
